Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform ...
Ozempic and its contemporaries are the new craze. But would you believe it when we say that these weight-loss drugs would be ...
Hamas Rejects Israeli 'Demand' Of Handing Over Dead Hostages In Exchange For Palestinian Prisoners Blocked By Netanyahu ...
The 2025 ACS report Cancer Statistics for African American and Black People, said that racial inequalities in care and ...
Obesity trends have stayed stable in the last couple years, whereas severe obesity has trended downward, a recently published report suggested.However, the percentage of people with a healthy weight ...
Looking for the latest stock opportunities in March 2025? We have you covered. Click to read our top stock picks to consider ...
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
Supplies of high-demand obesity drugs are improving – but they’re not easier to get - ‘There are a lot of people right now ...
HealthDay News — The number of U.S. adults with severe obesity increased from 2013 to 2023, according to a research letter published online Feb. 13 in the Journal of the American Medical Association.